Merck Meets all Financial Targets and Makes Significant Strategic Progress
Merck met all its financial targets and thus grew profitably in fiscal 2019. At the same time, Merck also made significant progress in executing its strategic agenda.
“We delivered on our promise and achieved growth for all our key performance indicators, namely net sales, EBITDA pre and EP ... more
3D printing of tablets
Merck and AMCM, Starnberg, Germany, announced a cooperation agreement on the 3D printing of tablets. AMCM offers customized additive manufacturing solutions. The cooperation targets GMP-conform (Good Manufacturing Practice) tablet formulation development and production for clinical trials i ... more
Merck Divests Allergopharma to Dermapharm
Merck signed an agreement to sell its allergy business Allergopharma to Dermapharm Holding SE. The transaction, which is expected to close by the end of the second quarter 2020, is subject to regulatory approval and satisfaction of other customary closing conditions.
Since 2007, Merck has m ... more